GBS Clinical Application
Screening for all pregnant women at 35-37 gestational weeks of regular prenatal checkups
Repeat screening at antenatal or intrapartum in high-risk pregnant women with GBS carriage
Pregnant women admitted to the hospital without GBS screening during pregnancy or after delivery
Premature rupture of fetal membranes
Fever >37.5°C at the time of delivery
GBS-positive pregnant women after giving the birth
Mothers and newborns with intrauterine infection during labor
Test Procedure (1)
1. Add 5 drops of each treatment reagent A and treatment reagent B to the reagent tube and mix thoroughly.
2. Put in the sampled swab, squeeze the reagent tube and rotate the swab 15 to 20 times, then leave the swab in the reagent tube for 5 minutes.
3. Squeeze the swab along the wall of the tube to squeeze out as much liquid as possible, then remove and discard the swab. Then cover the tube with a cap.
4. Add 3 drops of the treated sample solution to the spiked hole of the test card.
5. After 15 min, read the results within 20 min.
Characteristics and Strengths
◼ High sensitivity: Detectable in the early stages of infection
◼ High specificity: Not affected by other gram-positive bacteria, especially Staphylococcus aureus
◼ Great anti-interference ability: The application of antibiotics for a short time had no significant effect on the test results
◼ High detection rate: The detection and clinical compliance rates are >95%.
◼ User-friendly: One-step operation, 10-minute results, bedside diagnosis, samples on arrival
◼ Results given directly: Read the results either by eyes or an instrument